Close Menu

NEW YORK (GenomeWeb) – Two letters to the editor of the New England Journal of Medicine have pointed out possible flaws or omissions in a recent paper that suggested that a gene test could guide breast cancer treatment decisions.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.